Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
Clinical trial NCT03227419 · UNKNOWN
Trial details
- NCT number
- NCT03227419
- Sponsor
- Lille Catholic University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-22
- Primary completion
- 2024-09-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.